Rhonda Farnum

Chief Tech/Sci/R&D Officer at THERAVANCE BIOPHARMA, INC.

Net worth: 4 M $ as of 2026-05-30

61 year

Health Technology

Consumer Services

Profile

Rhonda F.
Farnum is currently Chief Business Officer & SVP-Medical Affairs at Theravance Biopharma, Inc., a position held since 2021, with employment at the firm starting in 2018.
Formerly, Ms. Farnum was Head of the Hematology Business Unit at Onyx Pharmaceuticals, Inc. from 2014 to 2015.
Education includes undergraduate studies at the University of Georgia.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
THERAVANCE BIOPHARMA INC 0.48%	2026-05-19	245,771 ( 0.48% )	4 M $	2026-05-30

Rhonda Farnum active positions

Companies	Position	Start
THERAVANCE BIOPHARMA, INC.	Chief Tech/Sci/R&D Officer	-

All active positions of Rhonda Farnum

Former positions of Rhonda Farnum

Companies	Position	End
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer	Corporate Officer/Principal	2015-07-31

See the detail of Rhonda Farnum's experience

Training of Rhonda Farnum

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rhonda Farnum's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer	Health Technology
University of Georgia University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Theravance Biopharma, Inc. Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases	Health Technology